NRX Pharmaceuticals Is Maintained at Buy by Ascendiant Capital

Dow Jones12/02 17:47

NRX Pharmaceuticals Price Target Raised to $45.00/Share From $44.00 by Ascendiant Capital

Dow Jones12/02 17:47

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024

PR Newswire11/26 21:03

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $19 Price Target

Benzinga11/25 21:38

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"

PR Newswire11/25 21:03

NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call Transcript Summary

Futuニュース11/19 09:02